Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Zydus receives approval from USFDA for Apixaban Tablets, 2.5 mg and 5 mg

    Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) for Apixaban Tablets, 2.5 mg and 5 mg (USRLD: Eliquis® Tablets).

  • Granules India Limited Received ANDA approval for Losartan Potassium Tablets

    Granules India Limited announced that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Losartan Potassium Tablets USP, 25 mg, 50 mg, and 100 mg.

    It is bioequivalent to the reference listed drug product (RLD), Cozaar Tablets of Organon LLC. Granules now has a total of 54 ANDA approvals from US FDA (52 Final approvals and 2 tentative approvals).

  • Dr. Reddys Lab acquire US business of Mayne Pharma

    Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy’s Laboratories Ltd announced that it has entered into a definitive agreement to acquire the U.S. generic prescription product portfolio of Salisbury, Australia, based Mayne Pharma Group Limited.

  • Workshop on Biomedical Waste Management Rules, 2016 for doctors and staff of SMS Medical College

    In association with IIHMR University, Jaipur, Rajasthan State Pollution Control Board organized a Workshop on Biomedical Waste Management Rules, 2016 for doctors and staff of SMS Medical College – Attached Hospitals" on Thursday, February 16, 2023. The workshop was held at the SMS Auditorium in Jaipur and was attended by more than 100 participants. 

  • Tablet-based screening doubles detection of psychosis symptoms in youth

    Asking patients to take a short survey on a tablet before their appointments may help mental health providers identify young people at risk of psychosis. A UC Davis Health study found that when patients took a 21-question pre-visit survey, more than twice as many were identified at risk of psychosis compared to those who did not complete the survey.

  • Establishment of a highly sensitive detection method for imidazole dipeptide oxidation derivatives

    Antioxidants discovered in meat! Osaka Metropolitan University researchers developed a new protocol for selective and highly sensitive detection, discovering five types of 2-oxo-imidazole-containing dipeptides(2-oxo-IDPs) using mass spectrometry. The 2-oxo-IDPs, present in living organisms, exhibit very high antioxidant activity, and were found to be abundant in meat including, beef, pork, and chicken.

  • The drug fasudil is found to reverse key symptoms of schizophrenia in mice

    A team from Nagoya University in Japan used the drug fasudil to reverse two common symptoms associated with schizophrenia: reduced density of pyramidal neurons and cognitive dysfunction associated with methamphetamine treatment. Their findings, which were published in Pharmacological Research, suggest new therapeutic approaches for treating schizophrenia patients.

  • HPCI Exhibition & Conference 2023

    HPCI Exhibition & Conference 2023 was held on 16 and 17 February, 2023 at Jio World Convention Centre, BKC, Mumbai. It was organised by ExpoNova Exhibitions & Conferences (India) Pvt. Ltd. It was focused on raw materials and techniques for the formulation of cosmetic and cleaning products. It is indeed a place where industry meets, discovers new ingredient and technology, learns about various innovation.

  • NIH RECOVER research identifies potential long COVID disparities

    Black and Hispanic Americans appear to experience more symptoms and health problems related to long COVID(link is external), a lay term that captures an array of symptoms and health problems, than white people, but are not as likely to be diagnosed with the condition, according to new research funded by the National Institutes of Health.

  • Toxic protein linked to muscular dystrophy and arhinia

    Researchers at the National Institutes of Health and their colleagues have found that a toxic protein made by the body called DUX4 may be the cause of two very different rare genetic disorders. For patients who have facioscapulohumeral muscular dystrophy (FSHD), or a rare facial malformation called arhinia, this research discovery may eventually lead to therapies that can help people with these rare diseases.

Subscribe to Pharma News